Filing Flows › Globus Medical (GMED) › Q3 2026 › vs Q3 2025
Globus Medical (GMED) Q3 2026 vs Q3 2025 (year over year)
Globus Medical's revenue fell $5.3M (-0.7%) from $769M in Q3 2025 to $764M in Q3 2026. The biggest changes: Musculoskeletal Solutions −$12.2M (-2%); Enabling Technologies +$6.8M (+24%). Operating margin 23.2% against 17.9% (+5.4 pts).
Globus Medical, Q3 2026: revenue $764M (-0.7% year over year), operating margin 23.2%, net earnings $141M, operating cash flow $265M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 23.2% | 17.9% | +5.4 pts |
| Net margin | 18.5% | 15.5% | +3.0 pts |
| Free cash flow margin | 29.4% | 27.8% | +1.6 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Musculoskeletal Solutions | $729M | $741M | −$12.2M | -2% |
| Enabling Technologies | $34.9M | $28.0M | $6.8M | +24% |
| Revenue | $764M | $769M | −$5.3M | -0.7% |
| Other income, net | $5.7M | $6.6M | −$914K | -14% |
| Operating profit | $178M | $137M | $40.2M | +29% |
| Costs & expenses | $586M | $632M | −$45.5M | -7% |
| Pre-tax earnings | $183M | $144M | $39.3M | +27% |
| Cost of revenue | $233M | $253M | −$19.6M | -8% |
| Research & development | $34.5M | $38.1M | −$3.5M | -9% |
| SG&A | $288M | $314M | −$25.1M | -8% |
| Other operating costs | $30.3M | $27.5M | $2.8M | +10% |
| Net earnings | $141M | $119M | $22.2M | +19% |
| Income tax | $42.1M | $25.0M | $17.1M | +68% |
| Depreciation & amortization | $70.4M | $71.1M | −$698K | -1% |
| Share-based compensation | $11.7M | $11.5M | $205K | +2% |
| Working capital & other | $41.9M | $48.1M | −$6.2M | -13% |
| Operating cash flow | $265M | $250M | $15.5M | +6% |
| Free cash flow (company-reported) | $225M | $214M | $11.0M | +5% |
| Purchases of property and equipment | $40.4M | $35.8M | $4.6M | +13% |
Questions
How much did Globus Medical's revenue grow year over year in Q3 2026?
Globus Medical's revenue fell $5.3M (-0.7%) from $769M in Q3 2025 to $764M in Q3 2026.
What drove Globus Medical's revenue change in Q3 2026?
Musculoskeletal Solutions −$12.2M (-2%); Enabling Technologies +$6.8M (+24%).